News
Pharmacy & healthcare news
Industry updates, regulation, and developments that matter to Indian pharmacies.
Cipla Launches AI-Powered Mobile Application for Asthma Screening in India
Cipla Limited has launched CipAir, an innovative AI-powered mobile application developed for early screening for asthma in India.
Dec 19, 2024
Russia’s Cancer Vaccine to Be Free for All: A Global Medical Milestone
Russia has recently announced a revolutionary mRNA cancer vaccine which is going to enter the market in early 2025. The new vaccine is going to be free and said to halt tumor growth besides preventing the spreading of the cancer, giving mankind a new hope to combat this terrible disease.
Dec 18, 2024
WHO and FAO Rank Foodborne Viruses; Norovirus, Hepatitis A, and E Top the List
The World Health Organization (WHO) and Food and Agriculture Organization (FAO) have, for the first time in one report, catalogued the foodborne viruses in terms of their rate of occurrence and severity.
Dec 18, 2024
₹1.85 crore worth of duplicate medicines seized in Bhiwandi; case filed against firm director and proprietor
₹1.85 crore worth of duplicate medicines seized in Bhiwandi; case filed against firm director and proprietor
Dec 17, 2024
Diabetes Drug Ozempic Linked to Increased Risk of Eye Condition, Studies Reveal
Two separate studies conducted by University of Southern Denmark, SDU confirm that patients suffering from Type 2 diabetes on the medication Ozempic doubled their risk of developing rare but severe eye condition termed Non-Arteritic Anterior Ischemic Optic Neuropathy that can cause permanent vision.
Dec 17, 2024
FDA Issues Black-Box Warning for Menopause Drug Veozah Over Liver Injury Risk
The US Food and Drug Administration has issued a black-box warning to Veozah, a medication prescribed for menopausal hot flashes, due to potential risks of serious liver injury.
Dec 17, 2024
Government Rules Out Ban on Ranitidine Despite Concerns Over Carcinogenic Impurities
The Indian government has stated that it will not ban the manufacturing and selling of Ranitidine, a very widely prescribed heartburn drug even in the wake of anxieties about the presence of N-nitrosodimethylamine (NDMA) linked to cancer. This decision follows a global ban and continued banter on its safety.
Dec 17, 2024
India's first gene therapy brings new hope for haemophilia patients
India has successfully developed its first human gene therapy, which employs a lentiviral vector to treat severe haemophilia-A, an unprecedented medical milestone with zero bleeding rates in the treated patients.
Dec 17, 2024
The Karnataka Government merges Food Safety and Standards with Drug Control Department, now named FDA.
The Karnataka government has clubbed the Department of Food Safety and Standards with the Drug Control Department to create the FDA, merging both into one unit. Therefore, Karnataka will be aligned like other states are, in particular Maharashtra, Tamil Nadu, Gujarat, and even Uttar Pradesh as they all operate through one FDA.
Dec 17, 2024
AIPAC launched its first MSME empowerment program in the pharma sector.
AIPAC initiated its first training and development program for Micro, Small, and Medium Enterprises in the pharmaceutical sector on 12 December 2024 at the Prestige Institute of Management & Research, Indore. More than 250 professionals attended to enhance regulatory compliance, skill development, and scientific excellence in the MSME segment.
Dec 16, 2024
Bavarian Nordic has partnered with Serum Institute to make mpox vaccine
The Danish biotech firm, Bavarian Nordic A/S has entered a deal with the Indian Serum Institute of India, SII for supplying its Mpox vaccines across Indian markets. The move is part of a development of increasing vaccine production in preparation to better prepare itself in light of the Mpox surges worldwide.
Dec 16, 2024
Steep hike in life-saving drug prices puts consumers at discomfort
A steep rise in the prices of essential life-saving drugs has left consumers in distress. Over the past six months, pharmaceutical companies have reportedly hiked the prices of medications for hypertension, diabetes, cancer, and gastrointestinal ailments by 20-50%.
Dec 16, 2024
UP Govt to Crack Down on Manufacturing, Sale of Counterfeit Medicines: Yogi Adityanath
Uttar Pradesh Chief Minister Yogi Adityanath has again reaffirmed the government's commitment toward tackling the manufacture and sale of spurious medicines in the state.
Dec 16, 2024
ICMR inaugurates the first diabetes biobank of India in Chennai to speed up the research
Exclusive: 15 December 2024, New DelhiIndian Council of Medical Research ICMR and the Madras Diabetes Research Foundation (MDRF) jointly launch the first-ever biobank for diabetes in India in Chennai.
Dec 15, 2024
USFDA Mandates Drug Recalls from Aurobindo, Glenmark, and Zydus Over Safety Concerns
Indian pharmaceutical majors Aurobindo Pharma, Glenmark, and Zydus Pharmaceuticals have recalled several products in the US market due to manufacturing-related quality issues flagged by the US Food and Drug Administration (USFDA).
Dec 15, 2024
1.5 Lakh fake antibiotic tablets were found in Nanded Government Hospital during regular testing
Exclusive: 14 December 2024, Chhatrapati SambhajinagarRoutine lab testing has found that an antibiotic tablet consignment of 1.5 lakhs supplied to a government hospital here in Nanded is spurious, containing less than the required medicinal substance.
Dec 14, 2024
30,000 Survival Kits for Heart Attack to Save Lives in Kota During Golden Hour
Heart Wise Society distributed over 30,000 survival kits for heart attacks in Kota to save more lives from heart attacks. These kits will provide life-saving treatment instantly during the golden hour, effectively handling symptoms of a heart attack and saving lives.
Dec 14, 2024
No Violation Found in Nestle Baby Food Sugar Norms: JP Nadda
Exclusive: 14 December 2024, New DelhiUnion Health Minister JP Nadda said on Friday in the Lok Sabha that tests conducted by the Food Safety and Standards Authority of India (FSSAI) did not find anything amiss with the sugar levels in wheat-based baby food sold by Nestlé in India.
Dec 14, 2024
DCGI Approves Rare Disease Drugs Quickly to Ensure Patients Get Them Sooner
The DCGI instructs state and Union Territory drug controllers to expedite the approval process for drugs treating rare diseases: It ensures that all the applications that have been raised, either for clinical trial or importing purposes, have to go through the same process by completion within 90 days, focused on patient access as well as the need of treatment for the patient.
Dec 13, 2024
Ayush Ministry Expands Pharmacopoeias and Amends Drug Act for Homoeopathy and Sowa Rigpa
The Union Ministry of Ayush amended the Drugs and Cosmetics Act, 1940 in a significant step to reinforce the traditional medicine frameworks with the inclusion of global standards in Homoeopathy and Sowa Rigpa systems of medicine.
Dec 12, 2024
Corrupt Ex-Drug Inspector, Family Jailed; Properties Worth lakhs seized.
Former drug inspector Kapil Dhiman has been sentenced to rigorous imprisonment for corruption and illegal wealth accumulation, along with his father and nephew.
Dec 12, 2024
FDA Issues Warning for Serious Risk of Liver Injury in Non-Cirrhotic PBC Patients Treated with Obeticholic Acid
The FDA has issued a safety alert concerning severe liver injury in patients with primary biliary cholangitis (PBC) treated with obeticholic acid (Ocaliva; Intercept Pharmaceuticals) who do not have cirrhosis.
Dec 12, 2024
Heart Health Warning: 42% Growth in Cardiac Drug Sales Reflects CVD Surge in Gujarat
Ahmedabad: Heart diseases (CVDs) are going up at an alarming rate in Gujarat. Sales of heart drugs saw a 42% spurt during the last two years. This is revealed by data that Pharmarack has been gathering from the market about sales of heart therapy drugs, which stood at ₹1,105 crore in November 2022 and jumped to ₹1,571 crore in November 2024. A big public health problem in itself.
Dec 12, 2024
Respiratory Drug Sales Surge Amid Pollution and Seasonal Illnesses
Breathing problems, due to pollution and seasonal changes, have resulted in a significant increase in the sales of respiratory drugs in India. Whether it was wet conditions due to monsoons or cold, polluted air during winter, sales of respiratory drugs increased multifold in 2024 with an impressive growth of 66% within five months.
Dec 12, 2024
Ready to simplify your pharmacy?
Start your free 7-day trial or book a personalised demo today.